PHGE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BiomX Inc. (PHGE) is not a good buy at the moment for a beginner investor with a long-term strategy. The company is facing significant challenges, including leadership instability, poor financial performance, and bearish technical indicators. While recent acquisitions in the defense sector could be a positive catalyst in the long run, the current pre-market price drop and lack of strong trading signals make this stock unsuitable for immediate investment.
The stock is currently in a bearish trend. The MACD histogram is negative and contracting, RSI indicates oversold conditions at 13.36, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support levels are at 2.069 and 1.623, with resistance at 3.513 and 3.959. Pre-market price is down 5.08%, indicating further weakness.
Recent acquisitions in the defense sector, including DFSL and Zorronet, could enhance the company's capabilities in AI-powered defense technologies and real-time threat tracking.
Leadership instability with the resignation of the CEO and Chairman, poor financial performance with declining net income and EPS, and a downgrade from analysts citing concerns about the company's future path.
In Q4 2025, revenue remained at 0 with no YoY growth. Net income dropped to -$13.34M, down 8.10% YoY. EPS fell to -8.18, a 45.86% decline YoY. Gross margin remained at 0 with no improvement.
H.C. Wainwright downgraded the stock to Neutral from Buy, citing leadership resignations and concerns about the company's future direction.
